TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Biotage Sweden AB
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
728,624
|
825,199
|
747,960 |
| Financial expenses |
1
|
28,403
|
6,353 |
| Earnings before taxes |
189,252
|
223,057
|
182,829 |
| EBITDA |
182,677
|
254,049
|
192,969 |
| Total assets |
681,332
|
548,708
|
530,927 |
| Current assets |
671,027
|
537,812
|
516,969 |
| Current liabilities |
260,892
|
251,973
|
205,608 |
| Equity capital |
411,548
|
289,249
|
309,394 |
| - share capital |
3,917
|
3,658
|
3,771 |
| Employees (average) |
92
|
93
|
95 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
60.4%
|
52.7%
|
58.3% |
| Turnover per employee |
7,920
|
8,873
|
7,873 |
| Profit as a percentage of turnover |
26.0%
|
27.0%
|
24.4% |
| Return on assets (ROA) |
27.8%
|
45.8%
|
35.6% |
| Current ratio |
257.2%
|
213.4%
|
251.4% |
| Return on equity (ROE) |
46.0%
|
77.1%
|
59.1% |
| Change turnover |
-155,129
|
99,718
|
50,233 |
| Change turnover % |
-18%
|
14%
|
7% |
| Chg. No. of employees |
-1
|
-2
|
-2 |
| Chg. No. of employees % |
-1%
|
-2%
|
-2% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.